Home / Lamotrigine / Austria
AT ATC N03AX09 · updated 2 Nov 2026
Lamotrigine shortage in Austria
Is there a Lamotrigine shortage in Austria?
Yes. As of 2 Nov 2026, 4 Lamotrigine products are reported short in Austria, the first since 29 Jun 2026. No return date has been given. Main reason: active ingredient shortage.
Also short in France, Italy, Spain, Ireland, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Lamotrigin 1A Pharma 25 mg - lösliche Tabletten, 30 Stück | 1 A Pharma GmbH | 29 Jun 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamotrigin 1A Pharma 50 mg - lösliche Tabletten, 30 Stück | 1 A Pharma GmbH | 1 Sep 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamotrigin Sandoz GmbH 25 mg - lösliche Tabletten, 30 Stück | Sandoz GmbH | 7 Sep 2026 | not given | Active ingredient shortage Verknappung des Wirkstoffes |
| AT | Lamictal 100 mg Tabletten (kaubar/suspendierbar), 50 Stück | Glaxosmithkline Pharma GmbH | 2 Oct 2026 | not given | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).